Novartis AG
ISIN: CH0012005267 | Ticker: NOVN | LEI: 5493007HIVTX6SY6XD66
Country: Switzerland
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions - Innovative Medicines and Sandoz - are supported by functional organizations with global scale.
Innovative Medicines
Made up of two business units, Novartis Pharmaceuticals which includes Novartis Gene Therapies, and Novartis Oncology & our Innovative Medicines Division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.
Sandoz
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.
1859
Served areaWorldwide
Headcount110,000
HeadquartersLichtstrasse 35, 4002 Basel – Switzerland
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 05.03.24 | None | Non-Executive member | Buy | CHF 210,000.00 |
| 05.03.24 | None | Non-Executive member | Buy | CHF 180,000.00 |
| 05.03.24 | None | Non-Executive member | Buy | CHF 97,500.00 |
| 05.02.24 | None | Executive member | Sell | CHF 76,577.27 |
| 02.02.24 | None | Executive member | Sell | CHF 1,358,618.79 |
| 02.02.24 | None | Executive member | Sell | CHF 160,484.80 |
| 30.01.24 | None | Executive member | Buy | CHF 1,157,807.87 |
| 30.01.24 | None | Executive member | Buy | CHF 417,611.45 |
| 21.11.23 | None | Executive member | Sell | CHF 1.00 |
| 27.09.23 | None | Executive member | Sell | CHF 1.00 |
CH0012005267
LEI5493007HIVTX6SY6XD66
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustrySMI
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.